Home > Category > Signaling Pathways > Membrane Transporter/Ion Channel > Apical Sodium-Dependent Bile Acid Transporter;ASBT > Clazosentan

克拉生坦

ChemLeader 98+%

Catalog No：CL2704 CAS No.：180384-56-9 MDLNo： Formula：C25H23N9O6S MW：577.57

Collect Share

Size	Availability	Price(USD)	VIP Price (USD)	Quantity
There is no price information at the moment, you can send an inquiry,and we will reply to you as soon as possible.

Chemical safety data sheet(MSDS)

Download MSDS

Inquiry Add To Cart

Product Overview
Related documents
Product details
Related literature

Product Overview

Product Name	Clazosentan
CAS	180384-56-9
Formula	C25H23N9O6S
MW	577.57
Appearance	Off-white to light yellow powder
Storage condition	Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years).

Product details

Clazosenta (Ro 61-1790, VML-588 and AXV-034) is a novel and highly potent endothelin A antagonist which improves cerebral blood flow and behavior after traumatic brain injury. Clazosentan is being developed in clinical trials for the treatment of patients with aneurysmal subarachnoid hemorrhage (SAH) by Actelion Pharmaceuticals.Clazosentant decreases and reverses cerebral vasospasm after experimental SAH. Clazosentanthas been shown to reduce vasospasm after aneurysmal subarachnoid hemorrhage (aSAH).

Related literature

Sorry, there is no relevant literature

Sorry, no related items

History

CL2704

Clazosentan

180384-56-9 98+%